Laboratory And Mouse Studies Show Targeted Drug Blocks The Growth Of Breast Cancer Ce

[News]

Using laboratory and mouse models of human breast cancer, researchers have found that a small molecule capable of targeting specific proteins on the surface of breast cancer cells can inhibit the growth of breast cancer cells that migrate to the brain. The small molecule used in the studies was the drug lapatinib (Tykerb®), which disrupts an important breast cancer metabolic process called the Her2/neu signaling pathway.

More... (http://www.medicalnewstoday.com/articles/116690.php)